
Indirect comparison links orforglipron 17.2 mg to 1.5% more weight loss and 0.3% more A1C lowering than oral semaglutide 25 mg in adults with type 2 diabetes.
Jonathan G. Marquess, PharmD, CDE, President and CEO of the Institute for Wellness and Education, Inc, discusses how all pharmacies can manage diabetes patients.
Jonathan G. Marquess, PharmD, CDE, President and CEO of the Institute for Wellness and Education, Inc, discusses how all pharmacies can manage diabetes patients.
This video was shot at the National Community Pharmacists Association 115th Annual Convention in Orlando.






